Background: Myocardial ischemia is a frequent finding in hypertrophic cardiomyopathy (HCM) and is often attributed to microvascular disease, extravascular compressive forces, reduced coronary flow ...

Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

The primary efficacy outcome was a composite of death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned ischemia-driven coronary revascularization, evaluated in a ...

myocardial infarction, stroke, or ischemia-driven revascularization. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF).

All studies comparing revascularisation with PCI with no treatment, usual care (post-revascularisation guided by imaging studies for viability or myocardial ischemia) or any other treatment in ...